Wall St Week Ahead: COVID-19 fears reappear as a threat to market | Reuters

Worries about a new strain of the virus, named Omicron and classified by the World Health Organisation as a variant of concern, slammed markets worldwide and dealt the S&P 500 index its biggest one-day percentage loss in nine months.

At least, investors said signs that the new strain is spreading and questions over its resistance to vaccines could weigh on the so-called reopening trade that has lifted markets at various times this year.

It isn’t over,” said David Kotok, chairman and chief investment officer at Cumberland Advisors.

The S&P 500 fell by a third as pandemic fears mushroomed in early 2020, but has more than doubled in value since then, though the pandemic’s ebb and flow has driven sometimes-violent rotations in the types of stocks investors favor.

Before Friday, broader vaccine availability and advances in treatments made markets potentially less sensitive to COVID-19.

At the same time, stocks that had rallied this year on bets of economic reopening may suffer if virus fears grow.

Each of these optimism collapses were a good buying opportunity,” wrote Bill Smead, founder of Smead Capital Management, in a note to investors.

Investors held out hope that markets could stabilize.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

…Read the full story